These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16673801)

  • 21. Infliximab efficacy in nail psoriasis. A retrospective study in 48 patients.
    Fabroni C; Gori A; Troiano M; Prignano F; Lotti T
    J Eur Acad Dermatol Venereol; 2011 May; 25(5):549-53. PubMed ID: 20707829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Marked improvement in nail psoriasis during treatment with adalimumab.
    Irla N; Yawalkar N
    Dermatology; 2009; 219(4):353-6. PubMed ID: 19851059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marked improvement in nail psoriasis during treatment with etanercept.
    Gómez Vázquez M; Navarra Amayuelas R
    Dermatol Ther; 2011; 24(5):498-500. PubMed ID: 22353156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes.
    Ellis CN; Krueger GG;
    N Engl J Med; 2001 Jul; 345(4):248-55. PubMed ID: 11474662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of alefacept in elderly patients and other special populations.
    Gottlieb AB; Boehncke WH; Darif M
    J Drugs Dermatol; 2005; 4(6):718-24. PubMed ID: 16302557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the efficacy of methotrexate and cyclosporine therapies on psoriatic nails: a one-blind, randomized study.
    Gümüşel M; Özdemir M; Mevlitoğlu I; Bodur S
    J Eur Acad Dermatol Venereol; 2011 Sep; 25(9):1080-4. PubMed ID: 21118309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ustekinumab for the treatment of nail psoriasis in heavily treated psoriatic patients.
    Vitiello M; Tosti A; Abuchar A; Zaiac M; Kerdel FA
    Int J Dermatol; 2013 Mar; 52(3):358-62. PubMed ID: 23330782
    [No Abstract]   [Full Text] [Related]  

  • 28. Current concepts and review of alefacept in the treatment of psoriasis.
    Krueger GG
    Dermatol Clin; 2004 Oct; 22(4):407-26, viii. PubMed ID: 15450337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe 20-nail psoriasis successfully treated by low dose methotrexate.
    Lee JY
    Dermatol Online J; 2009 Nov; 15(11):8. PubMed ID: 19951644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multicenter, open-label study of repeat courses of intramuscular alefacept in combination with other psoriasis therapies in patients with chronic plaque psoriasis.
    Krueger GG; Gottlieb AB; Sterry W; Korman N; Van De Kerkhof P
    J Dermatolog Treat; 2008; 19(3):146-55. PubMed ID: 18569270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of erythrodermic psoriasis with etanercept.
    Esposito M; Mazzotta A; de Felice C; Papoutsaki M; Chimenti S
    Br J Dermatol; 2006 Jul; 155(1):156-9. PubMed ID: 16792768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Approach to managing patients with nail psoriasis.
    Reich K
    J Eur Acad Dermatol Venereol; 2009 Sep; 23 Suppl 1():15-21. PubMed ID: 19686381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alefacept treatment for chronic plaque psoriasis.
    Dunn LK; Feldman SR
    Skin Therapy Lett; 2010 Apr; 15(4):1-3. PubMed ID: 20361167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alefacept: an expert review concerning the treatment of psoriasis.
    Langley RG; Cherman AM; Gupta AK
    Expert Opin Pharmacother; 2005 Oct; 6(13):2327-33. PubMed ID: 16218892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year.
    Rich P; Griffiths CE; Reich K; Nestle FO; Scher RK; Li S; Xu S; Hsu MC; Guzzo C
    J Am Acad Dermatol; 2008 Feb; 58(2):224-31. PubMed ID: 18083272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis.
    Lebwohl M; Christophers E; Langley R; Ortonne JP; Roberts J; Griffiths CE;
    Arch Dermatol; 2003 Jun; 139(6):719-27. PubMed ID: 12810502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis.
    Luger TA; Barker J; Lambert J; Yang S; Robertson D; Foehl J; Molta CT; Boggs R
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):896-904. PubMed ID: 19453794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the efficacy of acitretin therapy for nail psoriasis.
    Tosti A; Ricotti C; Romanelli P; Cameli N; Piraccini BM
    Arch Dermatol; 2009 Mar; 145(3):269-71. PubMed ID: 19289755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and use of alefacept to treat psoriasis.
    Krueger GG; Callis KP
    J Am Acad Dermatol; 2003 Aug; 49(2 Suppl):S87-97. PubMed ID: 12894131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alefacept: a review of the literature and practical guidelines for management.
    Hodak E; David M
    Dermatol Ther; 2004; 17(5):383-92. PubMed ID: 15379773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.